Sale!

FEXO 60

Original price was: 200.00৳ .Current price is: 180.00৳ .

  • Non-drowsy antihistamine tablet
  • Effective for allergic rhinitis and urticaria
  • Safe for children 6+ and adults
  • Produced by Square Pharmaceuticals

Generic

Fexofenadine Hydrochloride

Description

Fexo 60, produced by Square Pharmaceuticals Ltd., is a non-sedating antihistamine tablet containing 60 mg of Fexofenadine Hydrochloride. It’s designed to alleviate symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria in adults and children, effectively relieving sneezing, itchy eyes, and skin manifestations.

Benefits

  • Provides relief from seasonal allergic rhinitis symptoms
  • Alleviates chronic idiopathic urticaria skin symptoms
  • Reduces itching and sneezing without drowsiness
  • Effective for children and adults

Ingredients

Each tablet contains 60 mg of Fexofenadine Hydrochloride, an antihistamine targeting H1 receptors selectively to reduce allergy symptoms.

Uses and Doses

For adults and children aged 12 and above, Fexo 60 can be taken as 60 mg twice daily, 120 mg once daily, or 180 mg once daily, adjusting the dosage for impaired renal function. The recommended dose for children aged 6 to 11 is 30 mg twice or 60 mg once daily. Children 2 to 11 should take 30 mg twice daily in suspension form.

Side Effects

Common side effects include headache, nausea, dry mouth, and drowsiness. Some patients may also experience gastrointestinal discomfort.

How to Use

Administer orally, as prescribed. Avoid taking Fexo 60 with fruit juices and antacids containing magnesium or aluminum to prevent reduced absorption.

Pregnancy & Lactation

Fexofenadine Hydrochloride falls under category C for pregnancy by the FDA. It should be used during pregnancy or breastfeeding only if the benefits outweigh the potential risks to the fetus or infant.

Precautions and Warnings

Use cautiously in elderly patients and those with renal impairment. To maintain effectiveness, fruit juice consumption alongside fexofenadine should be avoided.

Safety Information

Not recommended for those with known allergies to any ingredients of Fexo 60. Avoid using certain antibiotics (e.g., Erythromycin) and antifungals (e.g., Ketoconazole) that may interact with Fexofenadine.

Indications

Used for seasonal allergic rhinitis and chronic idiopathic urticaria, relieving sneezing, itching, and skin manifestations.

Pharmacology

Fexofenadine is an antihistamine with selective H1-receptor-blocking activity. It does not cross the blood-brain barrier, reducing drowsiness. It is primarily excreted through feces, with minimal kidney processing.

Therapeutic Class

Non-sedating antihistamines

Storage Conditions

Store in a dry, cool place, protected from light and heat. Keep out of reach of children.

FAQ

  1. Can Fexo 60 be taken with fruit juices?
    No, avoid fruit juices as they may reduce Fexofenadine absorption.
  2. What should I do if I miss a dose?
    Take the missed dose as soon as possible, but skip it if the next dose is near. Do not double up doses.
  3. Is Fexo 60 suitable for children?
    Yes, it’s recommended for children aged 6 and above for tablet form and 2-11 years for suspension.

Disclaimer

This information is intended for general guidance only. Consult a healthcare provider for medical advice, especially if you are pregnant, nursing, or have a pre-existing medical condition.

Keywords: Fexofenadine, antihistamine, allergy relief, urticaria, non-sedating, Square Pharmaceuticals, allergic rhinitis, chronic urticaria, Fexo 60, allergy tablet, seasonal allergies, skin relief, H1 receptor antagonist, Fexofenadine Hydrochloride, safe for kids, no drowsiness, fast-acting, allergy medicine, trusted brand, high absorption.

Additional information

Weight 0.02 kg
Dimensions 2.5 × 1.5 × 0.5 in
Class -Dosage

Tablets

Size

60mg

Generics

Fexofenadine Hydrochloride

pharmaceuticals

Square Pharmaceuticals Limited

Brand

Square Pharmaceuticals PLC

Reviews

There are no reviews yet.

Be the first to review “FEXO 60”

Your email address will not be published. Required fields are marked *